A phase I/II trial of docetaxel (D) and oxaliplatin (O) in patients with advanced gastric cancer (AGC)

被引：0
|
作者：
Park, Y. [1 ]
Kim, K. [1 ]
Choi, M. [1 ]
Hong, J. [1 ]
Lee, E. [1 ]
Park, M. [1 ]
Kim, H. [1 ]
Lee, Y. [1 ]
Park, J. [1 ]
Lim, H. [1 ]
Kang, W. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15615
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Syma Iqbal
    Heinz-Josef Lenz
    David R. Gandara
    Stephen I. Shibata
    Susan Groshen
    Timothy W. Synold
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 85 - 91
  • [22] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Iqbal, Syma
    Lenz, Heinz-Josef
    Gandara, David R.
    Shibata, Stephen I.
    Groshen, Susan
    Synold, Timothy W.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 85 - 91
  • [23] Phase I study of docetaxel, oxaliplatin and S-1 (DOS) for patients with advanced gastric cancer
    Zang, D.
    Yang, D.
    Lee, H.
    Lee, B.
    Hwang, S.
    Kim, H.
    Song, H.
    Jung, J.
    Kim, J.
    Kwon, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 276 - 276
  • [24] Phase I/II study of docetaxel and S-I in patients with advanced gastric cancer
    Yamaguchi, K.
    Shimamura, T.
    Hyodo, I.
    Koizumi, W.
    Doi, T.
    Narahara, H.
    Komatsu, Y.
    Kato, T.
    Saitoh, S.
    Akiya, T.
    Munakata, M.
    Miyata, Y.
    Maeda, Y.
    Takiuchi, H.
    Nakano, S.
    Esaki, T.
    Kinjo, F.
    Sakata, Y.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1803 - 1808
  • [25] COMBINATION CHEMOTHERAPY (CT) WITH DOCETAXEL (D), OXALIPLATIN (O), CAPECITABINE (C) IN PATIENTS (PTS) WITH ADVANCED GASTRIC CANCER (AGC): RESULTS ON TOXICITY OF A PILOT STUDY
    Frustaci, S.
    Buonadonna, A.
    Turchet, E.
    Rosalen, S.
    Tumolo, S.
    Cannizzaro, R.
    Belluco, C.
    De Marchi, F.
    ANNALS OF ONCOLOGY, 2008, 19 : 183 - 183
  • [26] Phase II study of docetaxel (D) as salvage chemotherapy in patients with advanced gastric cancer
    Vanhoefer, U
    Harstrick, A
    Wilke, H
    Achterrath, W
    Preusser, P
    Stahl, M
    Fink, U
    Seeber, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S145 - S145
  • [27] Phase II study of docetaxel (D) as salvage chemotherapy in patients with advanced gastric cancer
    Wilke, H
    Vanhoefer, U
    Harstrick, A
    Achterrath, W
    Preusser, P
    Clemens, MR
    Thiel, E
    Flasshove, M
    Fink, U
    Seeber, S
    ANNALS OF ONCOLOGY, 1998, 9 : 52 - 52
  • [28] Phase II study of docetaxel, oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients
    Dima, G.
    Lucia, M.
    Caputo, A.
    De Simone, R.
    Olivito, V.
    Talarico, R.
    Pomillo, A.
    Filippelli, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 55 - 55
  • [29] PHASE II STUDY OF DOCETAXEL, OXALIPLATIN, FLUOROURACIL, AND FOLINIC ACID IN LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER PATIENTS
    Dima, G.
    Lucia, M.
    Caputo, A.
    De Simone, R.
    Olivito, V.
    Talarico, R.
    Filippelli, G.
    ANNALS OF ONCOLOGY, 2004, 15 : 73 - 73
  • [30] COMBINATION CHEMOTHERAPY (CT) WITH DOCETAXEL (D), OXALIPLATIN (O), CAPECITABINE (C) IN PATIENTS (PTS) WITH ADVANCED GASTRIC CANCER (AGC): PRELIMINARY RESULTS ON TOXICITY OF A PILOT STUDY
    Buonadonna, A.
    Cannizzaro, R.
    Colussi, A. M.
    Rosalen, S.
    Turchet, E.
    Tabaro, G.
    Frustaci, S.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S119 - S119
12345